三生国健股价跌5.02%，工银瑞信基金旗下1只基金位居十大流通股东，持有319.9万股浮亏损失988.5万元

Group 1 - The core viewpoint of the news is that Sangfor Health experienced a decline in stock price, dropping by 5.02% to 58.51 CNY per share, with a trading volume of 286 million CNY and a turnover rate of 0.78%, resulting in a total market capitalization of 36.088 billion CNY [1] - Sangfor Health, established on January 25, 2002, and listed on July 22, 2020, is primarily engaged in the research, production, and sales of antibody drugs. The revenue composition includes 75.24% from product sales, 15.37% from commissioned processing services, 7.94% from licensing services, and 1.44% from leasing services [1] Group 2 - From the perspective of the top ten circulating shareholders, a fund under ICBC Credit Suisse, specifically the ICBC Credit Suisse Frontier Medical Stock A (001717), entered the top ten shareholders in the second quarter, holding 3.199 million shares, which accounts for 0.52% of the circulating shares. The estimated floating loss today is approximately 9.885 million CNY [2] - The ICBC Credit Suisse Frontier Medical Stock A (001717) was established on February 3, 2016, with a latest scale of 9.33 billion CNY. Year-to-date returns are 42.65%, ranking 506 out of 4222 in its category; the one-year return is 46.43%, ranking 1914 out of 3795; and since inception, the return is 275.3% [2] - The fund manager of ICBC Credit Suisse Frontier Medical Stock A is Zhao Bei, who has a cumulative tenure of 10 years and 298 days, with a total fund asset size of 16.425 billion CNY. The best fund return during Zhao's tenure is 275.3%, while the worst return is -24.35% [2]